UF Health Recognized As National Leader for Treatment of Rare Inherited Disorder

UF Health has become one of only 40 VHL Alliance Clinical Care Centers in the United States.

The VHL Alliance is made up of leading healthcare organizations that specialize in treating von Hippel-Lindau (VHL) syndrome, a rare inherited disorder associated with tumors.

Hans Shuhaiber, M.D., a clinical assistant professor in the department of neurology in the UF College of Medicine and a member of the UF Health Cancer Center, said this recognition will ensure patients have access to the best treatment when they come to UF Health.

“UF Health’s inclusion in the Clinical Care Center network ensures that VHL patients will have access to top-tier care, innovative treatments and comprehensive support services,” said Shuhaiber. “The partnership not only enhances the quality of care, but also fosters a sense of community and empowerment among those affected by VHL and the clinicians providing VHL patients with groundbreaking treatment options.”

Being a member of the alliance allows for collaboration with other organizations to improve treatment outcomes and better understand the disease.

Read more: UF Health Recognized As National Leader for Treatment of Rare Inherited Disorder.